AccessPLUS Large Bore Hemostasis Valves, Catalog Code: 580758001, 580774001, IN8152/C, K04-01197, K05T-01863, K09-091... — FDA record Z-0904-2022

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Mar 1, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
AccessPLUS Large Bore Hemostasis Valves, Catalog Code: 580758001, 580774001, IN8152/C, K04-01197, K05T-01863, K09-09102B, K09-10388A, K09-12917, K09-13501AP, K10-05457AP, K10-05635, K10-05868P, K10-05872P, K12-08303, K12-10346, K12-10375, K12-10724AP, K12-10962, K12-11413, MAP150/F, MAP152/B, MAP152/F, K12-01551, K12-YP064A, K12-YP114, K12-YP115, K12-YS047A, IN8152, K12-01551
Reason
A design change made to a hemostasis valve to improve manufacturability caused an internal gap between the rotator and the Y-body, where the guidewire can get caught, resulting in difficulty advancing the guidewire through the device. This defect may result in a delay of procedure.
Classification
Class II
Recalling firm
Merit Medical Systems, Inc.
Quantity
58963
Agency-reported status
Ongoing
Source record identifier
Z-0904-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityCatalog Code/Lots: 580758001/P2073001; 580774001/I2219768; IN8152/C/H2292361, H2287442, H2281419, H2287443, H2298629, H2298630, H2305054, H2281405, H2305053, H2309362; K04-01197/H2296388; K05T-01863/T2313699; K09-09102B/H2308279; K09-10388A/H2285501; K09-12917/H2288582; K09-13501AP/H2265140; K10-05457AP/H2248304, H2265127, H2311255; K10-05635/H2285675, H2309893, H2305137; K10-05868P/H2278583; K10-05872P/H2275807, H2283595, H2309793, H2319811; K12-08303/H2266358, H2271477, H2295915 K12-10346/H2275972; K12-10375/H2290010; K12-10724AP/H2275826, H2299830; K12-10962/H2290113; K12-11413/H2262277, H2272368; MAP150/F/I2279928, I2259668; MAP152/B/P1908669, P1908670; MAP152/F/I2215502, I2259669, I2279933, I2289615, I2176727, I2289614, I2289616, I2279930; K12-01551/H2269831; K12-YP064A/H2288338, H2302500; K12-YP114/H2258787, H2288909, H2302503; K12-YP115/H2288352, H2302505; K12-YS047A/H2290278; IN8152/H2305053, H2305054, H2309362; K12-01551/H2269831

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US: MN, PA, AZ, FL, IL, AK, NY, CA, TX, KY, WI, NC, NJ, VA, CO, IN, AR, MO, LA, OR, MT, MA, MI, NE, WV, KS, MS, HI, IA, NH, ME, AL, DC, DE, NM, OH, GA, MD, TN, UT, RI, SC, OK, WA, ID, ND, SD, NV, VT. OUS: Poland, Germany, France, United Kingdom, Belgium, Korea, Republic of, Austria, Canada, Spain, Luxembourg, Italy, Switzerland, Czech Republic, Netherlands, Japan, Honduras, Colombia, Greece, Ireland

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Apr 20, 2022
Recall initiation date
Mar 1, 2022
Center classification date
Apr 11, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records